DEA Rethinks Telehealth Rx Rules, Now Open To Special Registration

The Drug Enforcement Administration has decided to revisit ways to expand telemedicine prescribing of controlled substances now that the COVID-19 public health emergency is over, including the possibility of a special registration approach it had earlier nixed, after receiving a near record-breaking number of public comments on controversial rules it floated in March that stakeholders roundly criticized as limiting, not expanding, virtual prescribing options. DEA announced Friday (Aug. 4) it will hold a public listening session Sept. 12 and 13...